Fragment Screening (XChem) at Diamond

Fragment screening has become increasingly popular over the last 10 years and is an approach that has revolutionised the pharmaceutical industry.
It provides valuable and cost-effective insights for rational drug design, enabling scientists to identify high-quality lead candidates in the early stages of discovery. Rather than focusing on a few large complex compounds, it explores a larger part of the existing chemical space from the drug targets of interest, providing new entry routes for the development of lead compounds.
At Diamond we provide a fully integrated facility, offering services from crystal cultivation through to targeting, harvesting and data collection & analysis using our high-powered research instruments.
To find out more, visit our web page.